Vol. 33 (4) 2026
Evaluating hepatitis C viremia and antiviral treatment barriers in hemodialysis patients in the post-HCV elimination era: Experience from Ain Shams University Hospitals … Original Research Article … The Egyptian Journal of Immunology E-ISSN (2090-2506)...
Vol. 33 (4) 2026
Immune signatures in primary hypertension: The roles of IL-10, IgM, and IgG … Original Research Article … The Egyptian Journal of Immunology E-ISSN (2090-2506) Volume 33 (4), October, 2026 Pages: 54–63. www.Ejimmunology.org...
Vol. 33 (4) 2026
Impact of probiotic supplementation on serum klotho levels and inflammatory status in patients with diabetic kidney disease … Original Research Article … The Egyptian Journal of Immunology E-ISSN (2090-2506) Volume 33 (4), October, 2026 Pages: 43–53....
Vol. 33 (4) 2026
Clinical significance of circulating regulatory T Cells, soluble CD25, and CXCL9 in assessing disease activity of vitiligo … Original Research Article … The Egyptian Journal of Immunology E-ISSN (2090-2506) Volume 33 (4), October, 2026 Pages: 28–42....
Vol. 33 (4) 2026
Autophagy – related protein 5: A promising biomarker for disease activity and treatment response in lupus nephritis … Original Research Article … The Egyptian Journal of Immunology E-ISSN (2090-2506) Volume 33 (4), October, 2026 Pages: 15–27....
Vol. 33 (4) 2026
Circulating regulatory B-cell subsets in type 2 diabetic nephropathy … Original Research Article … The Egyptian Journal of Immunology E-ISSN (2090-2506) Volume 33 (4), October, 2026 Pages: 01–14. www.Ejimmunology.org https://doi.org/10.55133/eji.330401...
